semaglutide atrial fibrillation afib and GLP-1 receptor agonists myocardial metabolism in Semaglutide Safety with Atrial Fibrillation: – Diabetes Mellitus and Atrial Fibrillation:

One large study published in The Journal of Clinical Psychiatry found that people with depression had 46 percent higher levels of C-reactive protein (CRP) in their blood

But that doesnt mean its smooth sailing

As long as the medicine continues to help with weight and health goals, and there are no serious side effects, long-term use can make sense for many people

Market Projections and Access Considerations Analyst projections suggest the GLP-1 market could reach $150 billion by 2030, driven by expanding indications and growing patient populations ^42

Speak with a licensed healthcare provider before starting treatment